Therapeutics of disordered movement
- PMID: 143204
Item in Clipboard
Therapeutics of disordered movement
Am Fam Physician.
1977 Sep.
Abstract
Human motor behavior is organized around two major neurotransmitter systems in the basal ganglia--dopaminergic and cholinergic. Hypokinetic disease may result from hypofunction of the dopaminergic system or cholinergic hyperfunction. The reverse seems true for many hyperkinetic movement disorders. Drugs which facilitate dopaminergic neurotransmission or which block cholinergic transmission relieve many hypokinetic disorders; the opposite approach is useful in treating many hyperkinetic disorders.
Similar articles
-
Involuntary movement disorders.Neurol Clin. 1984 Feb;2(1):71-89. Neurol Clin. 1984. PMID: 6239089 Review.
-
The pharmacology of extrapyramidal movement disorders.Monogr Neural Sci. 1973;2:1-136. Monogr Neural Sci. 1973. PMID: 4271860 Review. No abstract available.
-
Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects.Adv Biochem Psychopharmacol. 1980;23:381-6. Adv Biochem Psychopharmacol. 1980. PMID: 6446848 No abstract available.
-
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)].LARC Med. 1984 Feb;4(2):107-11. LARC Med. 1984. PMID: 6232436 Review. French. No abstract available.
-
The role of anticholinergic drugs in extra-pyramidal syndromes.Neuropharmacology. 1981 Dec;20(12B):1315-7. Neuropharmacology. 1981. PMID: 6119641 No abstract available.